Experiments were performed to determine whether platelets contain a membrane skeleton. Platelets were labeled by a sodium periodate/sodium [3Hjborohydride method and 1ysed with Triton X-100. Much of the filamentous actin could be sedimented at low g forces (15,600 g, 4 min), but some of the actin filaments required high-speed centrifugation for their sedimentation (100,000 g, 3 h). The latter filaments differed from those in the low-speed pellet in that they could not be depolymerized by Ca2+ and could not be sedimented at low g forces even from Triton X-100 lysates of platelets that had been activated with thrombin. Actin-binding protein sedimented with both types of filaments, but 3H-labeled membrane glycoproteins were recovered mainly with the high-speed filaments. The primary 3H-labeled glycoprotein recovered with this "membrane skeleton" was glycoprotein (GP) lb. Approximately 70% of the platelet GP lb was present in this skeleton. Several other minor glycoproteins, including >50% of the GP Ia and small amounts of three unidentified glycoproteins of M, > 200,000, were also recovered with the membrane skeleton. The Triton X-100 insolubility of GP Ib, GP Ia, a minor membrane glycoprotein of 250,000 Mr, and actinbinding protein resulted from their association with actin filaments as they were rendered Triton X-100-soluble when actin filaments were depolymerized with deoxyribonuclease I and coisolated with actin filaments on sucrose gradients. When isolated platelet plasma membranes were extracted with Triton X-100, actin, actin-binding protein, and GP lb were recovered as the Triton X-100 residue. These studies show that unstimulated platelets contain a membrane skeleton composed of actin filaments and actin-binding protein that is distinct from the rest of the cytoskeleton and is attached to GP Ib, GP Ia, and a minor glycoprotein of 250,000 M, on the plasma membrane.
Introduction
Unstimulated platelets have a characteristic discoid shape that is thought to be maintained at least in part by the coil of microtubules within platelets (1, 2) . However, platelets also contain much actin (3), -40% of which is filamentous in unstimulated platelets (4, 5) . By analogy to the erythrocyte, these filaments could act as a skeleton stabilizing the shape of the cell (6) . Evidence for such a possibility comes from the morphologic dem-onstration that actin filaments in unstimulated platelets are concentrated just beneath the plasma membrane' (4) and can be isolated from Triton X-1 00-lysed platelets as structures that maintain the discoid shape of the unextracted cell.2 Further evidence for a role of actin filaments comes from recent studies showing that cytochalasin B lowers the resistance of platelets to deformation (2) and that actin coisolates with platelet plasma membranes (7, 8) . For a submembranous actin filament skeleton to be important in regulating the shape of platelets, it would have to be attached to the plasma membrane. Despite the obvious importance of actin filament-membrane interactions in the functions of platelets and other cell types (5, 6) , little is known about the molecular nature of the interaction between actin filaments and plasma membranes in any cell type. One exception to this generalization is the characterization of actin filamentmembrane interactions in erythrocyte membranes (9) . Although glycoprotein (GP)3 Ilb and GP Illa have been implicated as attachment sites in activated platelets (10) , nothing is known about attachment sites in unstimulated platelets.
The present report shows that platelets contain a membrane skeleton that is distinct from the rest of the cytoskeleton. The major components ofthe membrane skeleton are actin and actinbinding protein. It is attached to GP Ib, GP Ia, and a Mr = 250,000 glycoprotein of the plasma membrane.
Methods
Isolation and surface labeling ofplatelet suspensions. The venous blood of healthy adult donors was collected into acid citrate/dextrose, and the platelet-rich plasma was obtained (1 1). Platelets were isolated by a centrifugation procedure as described previously (4) . Platelet-rich plasma was centrifuged at 730 g for 15 min, and the platelet pellet was washed two times in a buffer containing 120 mM sodium chloride, 13 mM trisodium citrate, and 30 mM dextrose, pH 7.0, and one time in a buffer containing 154 mM sodium chloride, 10 mM Tris-HCl, and 1 mM EDTA, pH 7.4. Platelets were finally resuspended at a concentration of 1 X 109 platelets/ml in Tyrode's buffer containing 138 mM sodium chloride, 2.9 mM potassium chloride, 12 mM sodium bicarbonate, 0.36 mM sodium phosphate, 5.5 mM glucose, 1.8 mM calcium chloride, and 0.4 mM magnesium chloride, pH 7.4. Various modifications of this general centrifugation procedure were employed depending upon the experiments to be performed. To obtain unstimulated discoid cells, prostacyclin (Sigma Chemical Co., St. Louis, MO) was included in the anticoagulant (50 ng/ml) and in all the washing buffers (10 ng/ml), which were preequilibrated at 37°C before use. Platelets were suspended in Tyrode's buffer that contained 10 ng/ml prosta-cyclin and were incubated in this buffer at 370C for at least 60 min before experiments were initiated (4) . To obtain platelets in which the discoid shape was lost and the majority ofthe preexisting actin filaments were cross-linked into networks that could be sedimented at low g forces from Triton X-I00-lysed platelets, platelets were isolated at ambient temperatures in the absence of prostacyclin (4) . Final platelet suspensions were resuspended at ambient temperatures in the absence of prostacyclin, and experiments were initiated immediately. For labeling by the sodium metaperiodate/sodium [3H]borohydride method, platelets isolated in the presence of prostacyclin were resuspended at 1 X 109 platelets/ml in a buffer containing 150 mM sodium chloride, 1 mM EDTA, and 10 mM Hepes, pH 7.6 and labeled as described by Berndt and Phillips (12) except that all buffers contained 10 ng/ml prostacyclin which was added just before use. Labeled platelets were finally resuspended in Tyrode's buffer containing 10 ng/ml prostacyclin and incubated at 370C for at least 60 min before use. When platelets were to be subsequently activated by addition of a platelet agonist, prostacyclin was omitted from the Tyrode's buffer. Platelet counts were determined with a Coulter counter (Coulter Electronics, Inc., Hialeah, FL).
Isolation and analysis of actin filaments and associated proteins. Platelets were lysed by addition of an equal volume of buffer containing 2% Triton X-100 (Sigma Chemical Co.), 100 mM Tris-HCl, pH 7.4 and, where indicated, 10 mM EGTA to chelate Ca2", 2 mg/ml leupeptin (Vega Biotechnologies, Tucson, AZ) to inhibit activity of the Ca2'-dependent protease or 2 mg/ml DNase I (beefpancreas, Boehringer Mannheim, Chicago, IL) (treated with 100 mM benzamidine and 2 mM phenylmethylsulfonyl fluoride) to depolymerize actin filaments. In some experiments, as indicated, platelets were suspended in Tyrode's buffer without added divalent cations and containing I mM EDTA, pH 7.4 and activated with 0.1 NIH U of thrombin/ml before lysis. Triton X-100-soluble and -insoluble fractions were separated by centrifugation at 4°C either for 4 min at 15,600 g or for 3 h at 100,000 g. Fractions were analyzed on SDS-polyacrylamide gels by the method of Laemmli (13) as described previously (14), on two-dimensional nonreduced-reduced gels by the method of Phillips and Agin (15) , or on two-dimensional gels by the method ofO'Farrell (16) as described previously (17) . The relative amounts of actin in the fractions were determined by densitometric scans of SDS-polyacrylamide gels (14). The relative amounts of radioactivity in 3H-labeled glycoproteins were determined by fluorography of gels treated with EN3HANCE (New England Nuclear, Boston, MA) and quantitated by liquid scintillation counting of the areas ofdried gels that superimposed with the bands of interest on the processed fluorograms (14). Glycoproteins in fractions obtained from unlabeled platelets were detected by the periodic acid-Schiffs staining technique (18) or by incubating Western blots, obtained by the method of Towbin et al. (19) , with antibodies against the glycoproteins of interest. Molecular weights were estimated by calibration of the gels with molecular weight markers (Bio-Rad Laboratories, Richmond, CA).
Analysis ofplatelet lysates by sucrose density gradient centrifugation.
Platelets were lysed by addition of an equal volume of Tyrode's buffer containing 2% Triton X-100 (Sigma Chemical Co.) and, where indicated, 2 mg/ml leupeptin (Vega Biotechnologies). Lysates were centrifuged at 15,600 g for 4 min, and 200 Ml of the supernatant was applied to a linear 5-25% sucrose gradient (volume = 5.0-5.2 ml) prepared in a buffer containing 2 mM calcium chloride, 0.2% Triton X-100, 1 mg/ml leupeptin, and 100 mM Tris-HCl, pH 7.4. Gradients were centrifuged in a SW55 rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA) using the integrator on a Beckman L8-70 ultracentrifuge set at w2t = 5.92 X 10" (=-5 h at 55,000 rpm, 390,000 g). The gradients were fractionated into 16-17 fractions from the bottom of the tubes, and the fractions were solubilized in an SDS-containing buffer for analysis on SDS-polyacrylamide gels. Sedimentation coefficients were determined as described by Martin and Ames (20) . The following proteins were used for calibration: catalase, S20,W = 11.30 (Boehringer Mannheim); y-globulin, S20,w (Sigma Chemical Co.). Bovine serum albumin iodinated by the lodobead method (21) and catalase iodinated by the Bolton-Hunter method (22) were included as internal standards in each sucrose gradient to relate separate runs of platelet lysates to the reference proteins. All steps were performed at ambient temperatures.
Isolation and Triton X-J00 extraction ofplatelet membranes. Platelet membranes were isolated from freshly drawn blood by a modification of the method described by Jennings and Phillips (23) . Briefly, washed platelets were suspended at a concentration of 4 X 109 platelets/ml in an ice-cold buffer containing 150 mM sodium chloride, 50 mM calcium chloride, 2 mg/ml leupeptin, 50 mM benzamidine (Sigma Chemical Co.), 1 mM phenylmethylsulfonyl fluoride, and 20 mM Tris-HCl, pH 7.4, and sonicated at 4VC in 1 -ml volumes four times for 10 s at 15-s intervals using a Branson Sonifier Cell Disruptor 200 (Danbury, CT) at output control setting 4. The sonicate was layered over an equal volume of 27% sucrose in the same buffer as the platelets (except that the leupeptin concentration was I mg/ml) and centrifuged for 3 h at 140,000 g. Membranes were recovered from the interface between the sucrose solution and the sonicate, diluted 10-fold (vol/vol) with 150 mM sodium chloride, 50 mM calcium chloride, 1 mg/ml leupeptin, 50 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, and 20 mM Tris-HCl, pH 7.4 and centrifuged at 80,000 g for 1 h at 4VC. The membrane pellet was resuspended at 4VC in the original platelet volume of the same buffer using a glass homogenizer to facilitate resuspension and extracted with Triton X-100 by addition of an equal volume of an ice-cold buffer containing 2% Triton X-100, 10 mM EGTA, 2 mg/ml leupeptin, 100 mM benzamidine, 2 mM phenylmethylsulfonyl fluoride, and 100 mM Tris-HCl, pH 7.4. Triton X-100-insoluble and -soluble fractions were separated by centrifugation for 3 h at 100,000 g.
Purification ofplatelet proteins. GP lb was extracted from fresh human platelets using the Triton X-1 14-containing lysis buffer described by Newman et al. (24) . GP lb, detected by periodic acid-Schiff's staining ( 18) of SDS-polyacrylamide gels, was recovered in the aqueous phase. This solution was treated with ice-cold Triton X-100 (1%, final concentration) and applied at a flow rate of 10 ml/h to an affinity column (1.5-ml bed volume) of wheat germ lectin coupled to Sepharose 6MB (Sigma Chemical Co.), previously equilibrated in a buffer containing 2.5 mM EDTA, 50 mM sodium chloride, 1% Triton X-100, and 50 mM Hepes, pH 7.4. The column was washed extensively with this same buffer, then with a buffer containing 1 mM EDTA, 0.1% Triton X-100, and 10 mM Tris-HCl, pH 7.4, and the bound material was finally eluted with the latter buffer containing 0.25 M N-acetyl glucosamine (Sigma Chemical Co.). Fractions of 1.35 ml were collected, and those containing GP lb were applied to a column (2.5 X 0.7 cm) of DEAE-cellulose (Whatman Chemical Separation, Inc., Clifton, NJ), previously equilibrated in 1 mM EDTA, 0.1 % Triton X-100, and 10 mM Tris-HCl, pH 7.4, at a flow rate of 15 ml/h. The column was washed and then eluted with a 120-ml linear gradient of 0-500 mM sodium chloride. GP lb eluted toward the middle of the gradient. The purified glycoprotein was homogeneous when stained by the periodic acid-Schiffs reagent; however, a sensitive silver stain (25) revealed the presence of 9 or 10 minor contaminants that were estimated, between them, to account for about 10% of the total protein.
Glycocalicin was obtained by a modification of the method of Okumura et al. (26) as developed by J. W. Lawler (personal communication). Briefly, platelets from fresh platelet concentrates (Peninsula Memorial Blood Bank, Burlingame, CA) were washed and resuspended in 1.0 M sodium chloride, 1 mM EDTA, and 20 mM Tris-HCl, pH 7.6. The suspension was stirred at 22°C for 1 h and then centrifuged at 50,000 g for 1 h at 4°C. The supernatant was dialyzed into a buffer containing 150 mM sodium chloride, 1 mM EDTA, and 20 mM Tris-HCI, pH 7.6 and applied to a column of wheat germ agglutinin coupled to Sepharose 6MB (Pharmacia Fine Chemicals, Piscataway, NJ). The column was washed with the same buffer containing 4.5 mM N-acetyl glucosamine (Sigma Chemical Co.) and then with the same buffer containing 450 mM N-acetyl glucosamine to elute glycocalicin. Glycocalicin was then further purified by hydroxylapatite chromatography (26) .
Actin-binding protein was purified from fresh human platelet concentrates as described previously (27) . Ca2l-dependent protease was purified from fresh human platelet concentrates (27) and dialyzed into a buffer containing 5 mM EDTA, 100 mM potassium chloride, 5 mM dithiothreitol, 0.02% sodium azide, and 50 mM Hepes, pH 7.4.
Antibody production and characterization. For generation of antibodies against glycocalicin, purified glycocalicin was electrophoresed through a 5% SDS-polyacrylamide gel. Protein was visualized by brief (-5 min) staining with Coomassie brilliant blue and cut out of the gel in a narrow strip. The strip was neutralized by two 15-min washes in 500 ml of 50 mM Tris-HCI, pH 7.8, homogenized with a Teflon homogenizer in 12 ml of the same buffer, and stored at -20'C. Antibodies were raised by injection ofthe homogenized gels into rabbits by standard procedures as described previously (27) . Antiserum was isolated by centrifugation of clotted blood for 20 min at 30,000 g. The IgG fraction was obtained by precipitation at 4VC with 40% ammonium sulfate. Antibody against GP UIb and GP Uila was a generous gift from Dr. Laurence Fitzgerald of the Gladstone Foundation Laboratories for Cardiovascular Disease, San Francisco. Antibodies against actin-binding protein and P235 were raised and characterized as described previously (27) . Rabbit anti-chick actin was purchased from Miles-Yeda (Elkhart, IN).
The specificity of antibodies was confirmed using the immunoblot technique ofTowbin et al. ( 19) . Platelet protein was first electrophoresed through SDS-polyacrylamide gels containing 7.5% acrylamide in the resolving gel. Polypeptides were then transferred electrophoretically to nitrocellulose paper, which was incubated with antibodies and then with '25l-labeled Protein A (purchased from Sigma Chemical Co. and radiolabeled by the lodo-bead method [21] ). Binding ofProtein A to antibodyantigen complexes was detected by autoradiography.
Results
Triton X-J00 insolubility of3H-labeled glycoproteins. Triton X-100 solubilizes most platelet proteins but does not solubilize actin filaments and other proteins that are Triton X-100-insoluble because of their filament association (28) . To determine whether any membrane glycoproteins were associated with actin filaments, the filaments were isolated by high-speed centrifugation (100,000 g for 3 h) from Triton X-100-lysed platelets in which the surface glycoproteins had been labeled by the sodium periodate/sodium [3H]borohydride method. As shown in Fig.  1 , several 3H-labeled glycoproteins were recovered in the Triton X-100-insoluble fraction. Their recovery was selective in that other 3H-labeled glycoproteins were recovered totally in the Triton X-100-soluble fraction. Much of the major 3H-labeled glycoprotein, GP Ib, was recovered in the Triton X-100-insoluble fraction. Several criteria were used to confirm that this major 3H-labeled glycoprotein was GP lb. First, it migrated further into SDS-polyacrylamide gels when reduced (Fig. I A) than when not reduced (Fig. I B) . Calibration of the gels with molecular weight markers showed that it had a Mr of 146,000 when reduced and one of 166,000 when not reduced; these values are in good agreement with those previously reported for GP Iba (Mr = 145,000) and the whole GP lb molecule (Mr = 160,000), respectively (29) . Second, on two-dimensional nonreduced-reduced gels, the glycoprotein migrated offthe diagonal line created by the majority of the platelet proteins in a position that was characteristic of GP lb (15, 29) (Fig. 2) . Third, this glycoprotein had a broad isoelectric point (pI) on two-dimensional gels prepared by the method of O'Farrell (16); this ranged from p1 6 to pI 8 (data not shown), a range that is similar to that reported previously for GP lb (29, 30) . Fourth, it reacted with monospecific antibodies raised against glycocalicin, the product of hydrolysis of GP lb by the Ca2"-dependent protease (31) (Fig. 3) .
In addition to GP lb, other glycoproteins were also selectively recovered in varying amounts in the high-speed Triton X-100-insoluble fraction (Figs. 1 and 2). Five of these were tentatively identified on nonreduced-reduced two-dimensional gels as GP Ia, GP Ha, GP lIb, GP 1I1a, and GP IV (Fig. 2) . The GP lIb and GP 1ila was confirmed on immunoblots using polyclonal antibodies specific for these glycoproteins (data not shown). Two additional glycoproteins that were often present in the high-speed Triton X-100-insoluble fraction from 3H-labeled platelets were identified only on the basis oftheir molecular weights (Mr -250,000 and 200,000) ( Fig. 1 ). Yet another had an even higher molecular weight and has been labeled in Fig. 1 with an arrow. These latter three glycoproteins were minor 3H-labeled glycoproteins and could only be detected upon long exposure of gels. Quantitation of the amount ofGP lb showed that 70.2±4.4% (mean±standard error, n = 3) was Triton X-100-insoluble. The remaining GP lb was quantitatively recovered in the Triton X- The nonreduced samples were electrophoresed in the first dimension on 7.5% SDS-polyacrylamide gels, reduced, and electrophoresed in the second dimension, again on gels of 7.5% acrylamide. 00-soluble fraction. GP Ia appeared to be >50% Triton X-I 00-insoluble. The remaining filament-associated glycoproteins (GP Ila, GP HIb, GP Illa, GP IV, and the three minor ones of Mr > 200,000) were present in the Triton X-l00-insoluble fraction in variable and usually quite small amounts. GP IV differed from the other glycoproteins in that its Triton X-00 insolubility was temperature-dependent. While similar amounts of most of the 3H-labeled glycoproteins were recovered in the Triton X-100-insoluble fraction at 4°C and at ambient temperatures, recovery ofGP IV in this fraction only occurred when buffers were employed at the lower temperature (Figs. and 2 compared with subsequent figures).
Because the sodium periodate/sodium [3H]borohydride procedure for surface-labeling platelets includes a step at which platelets are incubated at 4°C, a temperature shown previously to activate platelets (4), the recovery of glycoproteins with the Triton X-00-insoluble fraction was also studied in unlabeled platelets isolated by a method shown previously to produce unstimulated discoid cells (4) . Because GP lb was the major glycoprotein in the Triton X-100-soluble fraction from 3H-labeled platelets, the distribution of this glycoprotein was determined in the fractions from the unlabeled cells. In these experiments, GP lb was detected on immunoblots using the monospecific antibodies against glycocalicin. Quantitation of immunoblots, performed by gamma counting of the region of nitrocellulose that corresponded to the position ofGP lb on the autoradiogram, confirmed that the results were linear with respect to the concentration of GP lb (data not shown). The detection of GP lb on immunoblots in these experiments also removed the potential problem of only a small pool of GP lb being 3H-labeled by the sodium periodate/sodium [3H]borohydride method. Fig. 3 shows that the distribution ofGP lb between the Triton X-100-insoluble and -soluble fractions from unlabeled discoid platelets was similar to that in 3H-labeled platelets. The selective recovery of GP lb in the Triton X-100-insoluble fraction from unlabeled platelets was confirmed using nonreduced-reduced two-dimensional gels on which GP lb was detected as the major periodic acid-Schiff's staining protein on gels that were subsequently stained with Coomassie blue to visualize the diagonal obtained by the majority of the platelet proteins (data not shown). This method also showed that >50% GP Ia was present in the high-speed Triton X-100-insoluble fraction. In contrast, GP Ilb and GP Illa from the unlabeled discoid cells appeared to be recovered almost entirely in the Triton X-100-soluble fraction, a conclusion that was supported on immunoblots using antibodies against these glycoproteins (data not shown).
Relationship between actin filament content and Triton X-100 insolubility of3H-labeled glycoproteins. The presence of3H-labeled glycoproteins in the high-speed Triton X-100-insoluble fraction could have resulted from the association of these glycoproteins with actin filaments or from their inherent Triton X-100 insolubility. To distinguish between these possibilities, actin filaments were depolymerized, and the effect of this on the solubility of GP lb was examined. Two methods were used to depolymerize actin. In the first, filaments were depolymerized by the addition of DNase I to the lysis buffer (32) . In the second, Ca2+ was added to the lysis buffer to induce the Ca2+-dependent depolymerization of filaments by gelsolin (33, 34) .
Inclusion of DNase I in the lysis buffer caused depolymerization of 39.6±3.6% (mean±SE, n = 3) of the actin filaments (Table I ). The extent of depolymerization was greater (54.9±6.0%) when DNase I was added in the presence of Ca2', a result that is consistent with the known stimulatory effect of Ca2+ on DNase 1 (32, 35) . Fig. 4 shows the effect of DNase I on the polypeptides cosedimenting with actin filaments. As seen in this figure, many other Coomassie brilliant blue-stained polypeptides were present in the high-speed sediment. The major ones were actin-binding protein and P235 (identified on immunoblots, data not shown), and myosin heavy chain (14). The only other one that was identified was a-actinin (36). Comparison of the Triton X-100-insoluble and -soluble fractions (Fig. 4 ) showed that depolymerization ofactin filaments by DNase I was accompanied by the release of actin-binding protein into the Triton X-100-soluble fraction. The recovery of the other polypeptides in the Triton X-100-insoluble fraction appeared to be independent of the presence of actin. There was no evidence of any proteolysis caused by the presence of DNase I (Fig. 4) . Examination of the fluorogram obtained from 3H-labeled platelets (Fig. 4) , showed that depolymerization of actin by DNase I was accompanied by a decreased recovery of GP lb in the Triton X-100-insoluble fraction and an increased recovery of the glycoprotein in the Triton X-100-soluble fraction. Quantitation of the amount of GP lb in the Triton X-100-insoluble fraction showed that the release ofGP lb was greatest when DNase I was added in the presence of Ca2", which caused increased depolymerization of actin filaments (Table I) . Longer exposures of the gel shown in Fig. 4 revealed that the recovery of most of the other 3H-labeled glycoproteins in the Triton X-100-insoluble fraction was also decreased when actin filaments were depolymerized by DNase I (data not shown). The only exception was GP IV, the Triton X-100 insolubility ofwhich was independent of the actin filament content.
In contrast to DNase I, Ca2l had little effect on the recovery of 3H-labeled glycoproteins in the Triton X-100-insoluble fraction, despite the fact that it caused depolymerization of comparable amounts of actin filaments (Table I and Fig. 4 ).
Isolation ofthe membrane skeleton by differential centrifugation. The finding that depolymerization of actin filaments by DNase I, but not by Ca2", resulted in the release of GP lb from the Triton X-100-insoluble fraction suggested that GP lb might be bound to a pool ofactin filaments that could be depolymerized by DNase I but was resistant to depolymerization by gelsolin. In a previous report from this laboratory (4), we have shown that actin filaments in unstimulated, discoid platelets require high g forces (100,000 g for 3 h) to be sedimented from Triton X-100 lysates. In contrast, in platelets that have lost their discoid shape as a result of centrifugation in the absence of inhibitors of platelet function (such as prostacyclin), the majority of the filaments become cross-linked into networks that can be sedimented at low g forces (15,600 g for 4 min) (4, 28) . However, we have observed that a small percentage of actin filaments always remains in a form that requires high g forces to be sedimented. In the present study, experiments were designed to determine with which filaments the membrane glycoproteins were associated. Cross-linking ofactin filaments was induced either by washing platelets at ambient temperatures in the absence of prostacyclin or by labeling them by the sodium metaperiodate/sodium
[3H]borohydride method, a procedure that was found to cause partial activation ofplatelets. Cross-linked filaments were isolated by centrifugation of Triton X-l00 lysates at low g forces, and the remaining filaments were subsequently isolated from the Triton X-100 supernatant by high-speed centrifugation. In accord with previous publications (10, 28) , the only major Coomassie brilliant blue-stained polypeptide recovered with the actin filaments sedimenting at low g forces was actin-binding protein (Fig. 5) recovered with these filaments. The remaining Triton X-100-insoluble polypeptides required high-speed centrifugation for their sedimentation, as did a small amount of the filamentous actin (Fig. 5, lane 3) . Comparison of the two Triton X-100-insoluble fractions showed that most of the Triton X-100-insoluble glycoproteins were recovered with the small amount of filamentous actin that required high g forces for its sedimentation (Fig. 5 ). Fig. 6 shows that those filaments that could be sedimented at low g forces were depolymerized by addition of either DNase I or Ca2" to the Triton X-100 lysis buffer. In contrast, those filaments requiring high g forces for their sedimentation were depolymerized only by DNase I, with the effect ofDNase I being greatest in the presence of Ca2" (Fig. 6) . The Ca2" alone did not depolymerize these actin filaments (Fig. 6 and Table II ). This experiment was performed with unlabeled platelets, therefore the effect of DNase I and Ca2" on the distribution of GP Ib was determined on immunoblots using antibody against glycocalicin. Fig. 6 shows that the release ofGP lb from the high-speed Triton X-00-insoluble fraction correlated with the extent of depolymerization of the actin filaments. Fig. 7 shows the results of an experiment in which platelets that had not been surface labeled were stimulated with thrombin for increasing lengths of time. The experiment was performed * Platelets were lysed by addition of an equal volume of 2% Triton X-100, 10 mM EGTA, 2 mg/ml leupeptin, 100 mM benzamidine, 2 mM phenylmethylsulfonyl fluoride, and 100 mM Tris-HCI, pH 7.4. The low-speed Triton X-100-insoluble fraction was isolated by centrifugation at 15,600 g for 4 min; the high-speed Triton X-l00-insoluble fraction was isolated by the subsequent centrifugation of the low-speed supernatant at 100,000 g for 3 h. The effect of Ca2' on the actin in the low-speed sediment was determined by adding 3.5 ,l of 1 M calcium chloride and 3.5 gl of 1 M sodium hydroxide to each ml of platelet lysate, whereas the effect on the actin in the high-speed sediment was determined by adding the calcium chloride and sodium hydroxide to the supernatant obtained after the low-speed centrifugation. Values given are mean±standard error from three donors. $ Significant depolymerization relative to the samples that had no addition; P < 0.005 in a two-sided, paired t test. in the presence of EDTA to prevent platelet aggregation and thus to permit the efficient lysis ofactivated platelets with Triton X-100 and the subsequent separation of the Triton X-100-insoluble actin filaments into those that sediment at low g forces and those that require high g forces for their sedimentation. Consistent with previous reports (28, 37) , activation of platelets resulted in rapid polymerization of actin, as indicated by decreased actin in the Triton X-100-soluble fraction (Fig. 7) . The increased actin filament content was observed entirely in the low-speed Triton X-100-insoluble fraction. After an initial decrease, the amount of actin in the high-speed Triton X-100-insoluble fraction remained constant. The previously reported increases in the amount of actin-binding protein, myosin, aactinin, and fibrin sedimenting at low g forces with the actin filaments from thrombin-activated platelets (10, 14, 28, 38) were accompanied by decreases in the amount of these proteins sedimenting at high g forces. Examination of the distribution of GP lb on immunoblots confirmed that most of the GP lb was recovered with those filaments requiring high-speed centrifugation for their sedimentation and showed that the distribution of this glycoprotein between the Triton X-100-insoluble and -soluble fractions was not changed during platelet activation. Isolation ofthe membrane skeleton by sucrose density centrifugation. Fig. 8 shows the results of an experiment in which GP lb associated with the membrane skeleton was separated from the Triton X-100-soluble form of GP lb by sedimentation through sucrose density gradients. The distribution of GP lb in the sucrose gradient fractions was determined by fluorography of SDS-polyacrylamide gels of each fraction. Glycoprotein lb was detected in three positions in the gradient. The greatest concentration ofGP lb was observed in fractions containing proteins with sedimentation coefficients centering at 8.4 S. The GP IbIlla complex, shown previously to have a sedimentation coefficient of 8.6 S (23), was also present in these fractions. Lesser amounts of GP lb were also recovered in several fractions lower 3 4 5 6 7 8 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 in the sucrose gradient, corresponding to sedimentation coefficients ranging from 10.3 to 15.0 S (Fig. 8) . Finally, variable amounts of GP lb were also recovered in the pellet that sedimented to the bottom of the gradient (data not shown). In contrast, purified GP lb was recovered with a sedimentation coefficient of 5.0 S (data not shown). Thus, the GP lb in platelet lysates existed in multiple forms, all of which sedimented faster than the purified protein. These data suggest that GP lb was associated with additional proteins in the Triton X-100 lysates of platelets. Sedimentation of Triton X-100-soluble fractions through sucrose density gradients showed that the GP lb with a sedimentation coefficient of 8.4 S was the Triton X-100-soluble form of the glycoprotein (data not shown). The GP lb sedimenting lower in the gradient therefore represented that which was associated with the membrane skeleton. though not visible on the gels containing 5% acrylamide (a condition that is necessary for the efficient resolution of GP lb in Fig. 8) , actin was demonstrated to be present in these fractions by electrophoresis of sucrose gradient fractions on gels containing 7.5% acrylamide (Fig. 9) .
Isolation ofthe membrane skeleton from membrane vesicles.
The co-sedimentation of actin-binding protein, GP lb, GP Ia, and the glycoprotein of M, = 250,000 with the high-speed actin filaments from Triton X-100 lysates of unstimulated platelets and the co-isolation of these proteins on sucrose gradients suggested that these were the components of the membrane skeleton in platelets. As a test of this hypothesis, plasma membranes were isolated from platelets and examined for the presence of each of the proteins. The major proteins, detected by Coomassie brilliant blue, were actin, actin-binding protein, GP IIb, and GP IIla (Fig. 10) . The identity of each of these proteins was confirmed on immunoblots (data not shown). As shown in the immunoblot in Fig. 10 , GP lb was also present in the membrane fraction.
After extraction of the membranes with Triton X-100, most of the GP I1b and GP lIIa was solubilized. In contrast, much of the GP lb was insoluble in Triton X-100 and was recovered with the membrane skeleton. The major components of this skeleton were actin, actin-binding protein, and GP lb (Fig. 10, lane 2) .
In experiments using 3H-labeled platelets, it was found that GP Ia and the membrane glycoprotein of Mr = 250,000 were also recovered with the membrane skeleton obtained from isolated membrane vesicles (data not shown).
Discussion
Previous studies indicate a close association of actin filaments with platelet plasma membrane: submembranous networks of actin filaments have been demonstrated morphologically in platelets,' and actin co-isolates with membranes during their purification (7, 8) . It has therefore been assumed that actin filaments within platelets are attached to the plasma membrane. Although one study using platelets surface-labeled by lactoper- oxidase-catalyzed iodination implicated GP Ilb and GP Illa as attachment sites in platelets that had aggregated, no major iodinated glycoprotein was recovered with filaments isolated by low-speed centrifugation from Triton X-100 lysates of unstimulated platelets (10) . However, we have demonstrated that some of the filamentous actin in platelets does not sediment at the low g forces used in the previous study but requires high g forces to be sedimented (28) . In the present study, it is shown that these latter filaments represent a specific membrane skeleton that is distinct from the rest of the cytoskeleton.
Three lines of evidence support the conclusion that platelets contain a distinct membrane skeleton. First, by labeling platelets with the sodium metaperiodate/sodium [3H]borohydride procedure, it was shown that several glycoproteins were selectively associated with the filaments requiring high g forces for their sedimentation. Second, unlike those filaments that sedimented at low g forces, those requiring high g forces for their sedimentation were resistant to depolymerization by gelsolin. Third, during platelet activation, when actin filaments that could be sedimented at low g forces underwent increased polymerization and, as reported previously, became cross-linked into dense structures (28) , the filamentous actin requiring high g forces to be sedimented, together with the 3H-labeled glycoproteins associated with them, still remained as separable structures.
In addition to actin, many Coomassie brilliant blue-stained polypeptides and several 3H-labeled glycoproteins co-sedimented with the membrane skeleton at high g forces. The principal 3H-labeled glycoprotein recovered with the membrane skeleton was GP Ib, >70% of which was Triton X-100-insoluble. Other glycoproteins that were Triton X-100-insoluble included GP Ia, GP IHa, GP lIb, GP IIIa, and three unidentified glycoproteins ofMr > 200,000. Although only small amounts of most ofthese glycoproteins were associated with filaments, their interactions were specific as indicated by the absence of other, more intensely 3H-labeled glycoproteins from the Triton X-100-insoluble fraction.
The sodium metaperiodate/sodium [3H]borohydride procedure used to label the surface glycoproteins includes a step in which platelets are incubated at 4°C, a temperature that has been shown to cause at least partial activation of platelets (4) . Prostacyclin was therefore included in all buffers to minimize this effect; however, the appearance of small aggregates of plate-
Fluorogram
Protein Stain Figure 9 . Glycoprotein lb is one of the major plasma membrane glycoproteins in platelets, being present in -25,000 copies per platelet (41) . The association of >70% of this glycoprotein with the actin filaments of the membrane skeleton therefore suggests that this glycoprotein is a primary attachment site for the membrane skeleton in unstimulated platelets. In a recent morphologic study, we have shown that the majority of actin filaments in unstimulated, discoid platelets appear to be concentrated beneath the plasma membrane.' Thus, in discoid cells, the filaments of the cytoskeleton, as well as those of the membrane skeleton, may be attached to membrane glycoproteins. Alternatively, the peripheral location of the cytoskeleton could result from its interaction with other peripheral structures such as microtubules or the membrane skeleton. In the previous study, filaments in platelets that had lost their discoid shape during their isolation by centrifugation procedures appeared to be more centralized than those in discoid platelets,' suggesting that disruption of the interaction that concentrates the cytoskeleton at the periphery may be one of the very early steps in platelet activation. In contrast, the present study shows that the interaction of the membrane skeleton with the plasma membrane remains intact during platelet activation. Because the platelets used in the present study were necessarily surface-labeled by a procedure known to cause some activation of platelets, an interaction between filaments of the cytoskeleton and plasma membrane glycoproteins may have gone undetected in this study. Solum and Olsen (42) recently reported that GP lb was present in the Triton X-I 00-insoluble fraction ofplatelets. However, because these authors isolated the Triton X-100-insoluble fraction by low-speed centrifugation, they were presumably detecting only a small amount of the filament-associated GP lb. In an earlier publication, Solum et al. (43) showed by crossed immunoelectrophoresis that GP lb in the low-speed Triton X-100 supernatant was present in three forms. These forms were identified as glycocalicin, free GP Ib, and a high molecular weight complex of GP lb with other unidentified proteins. The present report suggests that this high molecular weight form of GP lb represents GP lb associated with actin filaments ofthe membrane skeleton.
Platelet Membrane Skeleton The use of sucrose density gradients in the present study permitted the demonstration of additional interactions involving GP lb in platelet lysates. GP lb that was not associated with the membrane skeleton in platelet lysates had a sedimentation coefficient of 8.4 S. Such a value is similar to that of the GP Ilb-Illa complex (Mr = 265,000 [23] ) and is markedly different from the sedimentation coefficient (5.0 S) of purified GP Ib, which has a Mr = 160,000 (29) . This indicates that GP lb is associated with an additional polypeptide(s), an interaction that is maintained in the presence of Ca2+-dependent proteolytic activity (40). A candidate for such a polypeptide is the one of Mr = 210,000 reported previously to co-purify with GP lb (44) . Another candidate is GP IX, which has been shown to co-purify with GP lb on anti-GP lb monoclonal antibody affinity columns (45) . The method of purifying GP lb described in the present study presumably separated GP lb from the other polypeptides to which it was associated in platelets. The results of sucrose density gradient sedimentation reported here suggest that the form identified as free GP lb on crossed immunoelectrophoresis (43) may have been complexed with an additional unidentified protein(s).
The recovery of several glycoproteins with the membrane skeleton suggests that the filaments of this skeleton may be attached to more than one site on the plasma membrane of unactivated platelets. Such a mechanism would not be unprecedented. In erythrocytes, which are the only cell type in which the molecular nature of the interaction of actin filaments with integral membrane proteins has been described in detail, filaments are attached to spectrin, which is itself linked to at least two integral membrane proteins: glycophorin and band 3 (9) . The interaction between spectrin and glycophorin is mediated by band 4.1, whereas that between spectrin and band 3 is mediated by ankyrin (9, 46) . Because spectrin, band 4.1, and ankyrin have all been detected immunologically in platelets (47, 48) , similar attachment mechanisms may exist within these cells. In addition, a-actinin and vinculin, two other proteins thought to be involved in the attachment of actin filaments to plasma membranes in nonmuscle cells, have also been detected in platelets (36, 49), providing further support for the idea that actin filaments may be attached to the platelet membrane in a number of ways. Alternatively, the recovery of some of the glycoproteins with actin filaments might result from the presence of complexes of these glycoproteins with glycoproteins comprising the true attachment sites. GP Ib, for example, has been purified as a complex with a polypeptide of Mr = 210,000 (44) . The latter glycoprotein might represent one ofthe high molecular weight glycoproteins recovered with actin filaments in the present study.
The attachment of a submembranous network of actin filaments to the plasma membrane of unstimulated platelets could, by analogy to the erythrocytes, have an important functional role in controlling the shape and deformability of the platelets. The involvement of GP lb in such a mechanism is supported by the observation that platelets from Bernard-Soulier patients, which lack GP lb (50) , are unusually large and readily deformable (51, 52). In some cell types, the attachment offilaments to membrane glycoproteins has also been shown to influence the properties ofthe glycoproteins themselves, restraining their mobility in the plane of the membrane and, under certain conditions, directing their mobility (6, 53) . It is thus reasonable to suggest that the properties of GP lb may also be influenced by its attachment to actin filaments. Because GP lb appears to be the receptor for von Willebrand factor and thus to be involved in supporting the adhesion ofplateiets to the subendothelium (54), regulation of the properties of GP lb by its attachment to actin filaments could be of clinical significance.
